当前位置:
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
FDA approves first deuterated drug
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-04-28 00:00:00 , DOI: 10.1038/nrd.2017.89 Asher Mullard
Nature Reviews Drug Discovery ( IF 122.7 ) Pub Date : 2017-04-28 00:00:00 , DOI: 10.1038/nrd.2017.89 Asher Mullard
The FDA approved Teva Pharmaceuticals' deutetrabenazine for chorea associated with Huntington disease, providing the first approval of a drug that contains the heavy hydrogen isotope deuterium.Early adopters first started tinkering with the use of deuterium in drug candidates more than 50 years ago.
中文翻译:
FDA批准首个氘化药物
FDA批准了Teva Pharmaceuticals的氘代丁苯那嗪治疗与亨廷顿病相关的舞蹈病,这是对包含重氢同位素氘的药物的首批批准.50年前,早期采用者首先开始尝试在候选药物中使用氘。
更新日期:2017-05-18
中文翻译:
FDA批准首个氘化药物
FDA批准了Teva Pharmaceuticals的氘代丁苯那嗪治疗与亨廷顿病相关的舞蹈病,这是对包含重氢同位素氘的药物的首批批准.50年前,早期采用者首先开始尝试在候选药物中使用氘。